Hardware Podcasts

216 - How UAE and Singapore Are Redefining Regulatory Innovation with Stephen O'Rourke

Let's Combinate · 3 Dec 2025 · 21m

What this episode covers

Stephen O'Rourke, founder of the consultancy Clarifi, discusses regulatory strategy for MedTech, biotech, and novel food startups navigating EU and US pathways. He highlights the hidden costs of regulatory failure, emphasizing the need for early engagement with agencies and the importance of UDI compliance across all departments. O'Rourke also explores emerging regulatory models in the UAE and Singapore, explaining how regulatory sandboxes and national initiatives are accelerating innovation, and shares insights from his run for the European Parliament on how policy is made.

Most relevant to

companies scaling up

Topics

Mentioned

Companies
Clarifi
Also
Medtech Chopsticks, GUDID, EU MDR, UAE, Singapore

Related episodes from other shows

Other shows on the same ground, closest first.

  • Global Medical Device Podcast · 40m

    Challenges for Regulatory Submission: EU vs. US

    Michelle Lott, Founder of leanRAQA and former FDA DGMPAC member, explains the severe regulatory hurdles of the EU MDR compared to the US FDA pathway, noting that 18,000 MDD certificates were issued but only 1% have transitioned to MDR. She highlights that companies face exorbitant notified body fees, a bottleneck of only 28 notified bodies, and the requirement for ISO 13485 certification, leading many small and large firms to withdraw from the EU market. Lott advises startups to perform a market analysis to determine if their revenue model supports these recurring costs, warning that 'hope is not a regulatory strategy' as certificates expire in May 2024. The discussion covers the shift from a linear US submission process to a continuous, living system in the EU, including annual audits and recertification every three years.

    Certification & complianceStarting a product company
    7 chapters

  • Global Medical Device Podcast · 31m

    #466: Leaving the Ivory Tower - How Notified Body Engagement Unlocks Startup Growth

    Malte Knowles Schmidt, Global Portfolio Lead for Medical Device Software, AI, and Cybersecurity at TÜV SÜD, explains how early-stage medtech startups can demonstrate regulatory maturity to investors before achieving full certification. He advocates for 'leaving the ivory tower' by engaging notified bodies early, implementing an enterprise Quality Management System (eQMS), and pursuing partial ISO 13485 certification for core design processes. Schmidt warns against 'Pyrrhic certifications' where commercial viability is sacrificed for regulatory approval and suggests using external testing as strategic evidence of progress.

    Validation & product-market fitCertification & compliance
    6 chapters

  • Global Medical Device Podcast · 50m

    The Best of Jon & Mike Through the Years

    Jon Speer, founder of Greenlight Guru, and Mike Drues of Vascular Sciences reflect on their 107-episode podcast partnership, discussing key regulatory strategies including the 510(k), De Novo, and Emergency Use Authorization (EUA). They emphasize the importance of understanding all market pathways, interpreting regulations rather than just following them blindly, and conducting realistic usability testing. The conversation highlights the critical mindset of asking whether one would use the device on a family member, underscoring the gravity of medical device development.

    Certification & complianceSensors & measurement in products
    6 chapters

  • Global Medical Device Podcast · 32m

    Understanding the Value of a Medical Device Guru

    Tom Rish, Senior Medical Device Guru and manager of the Guru team at Greenlight Guru, explains how the company provides mentorship and regulatory support to medical device companies beyond its QMS software. He discusses the 'Guru Edge,' emphasizing a phased 'build as you go' approach to quality systems to help startups launch products and pass audits without being overwhelmed by paperwork. Rish highlights industry trends including the rise of wearables, software as a medical device (SaMD), and the impact of EU MDR and IVDR regulations on In Vitro Diagnostics (IVD).

    Medical & health devicesCertification & compliance
    7 chapters

  • Global Medical Device Podcast · 52m

    #357: The State of UDI Across the World

    Gary Saner, a UDI expert and co-chair of the industry's structured product labeling technical team, discusses the evolving global landscape of Unique Device Identification (UDI) compliance with host Etienne Nichols. Saner highlights critical upcoming deadlines in the European Union, specifically the potential 2025 mandatory reporting window, and contrasts these with the simpler, US-aligned implementation in Australia. He outlines common pitfalls such as data cleansing, deprecated nomenclature, and the failure to build scalable, global systems, while recommending early engagement with technology solutions like ReedTech to manage complex regulatory requirements.

    Certification & complianceSourcing & supply chain
    7 chapters

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Let's Combinate. The episode itself belongs to its publisher.